Pravastatina Kern Pharma 40 mg comprimidos EFG, Placebo Pravastatina
IIBSP-PRE-2024-198
Phase 3 small_molecule active
Quick answer
Pravastatina Kern Pharma 40 mg comprimidos EFG, Placebo Pravastatina for intrauterine growth restriction, preeclampsia is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- intrauterine growth restriction, preeclampsia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active